In addition, the majority of the T2DM group was on statin and aspirin therapy; both of which are known to reduce CD36 levels [22] therefore it is likely that the levels noted in this study for the T2DM group are lower than expected. This evidence concerns the gene CD36 and type 2 diabetes mellitus.